Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.58 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.56 |
| ▸ | TYR | P14679 | 1/20 | 0.56 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.56 |
| ▸ | ERN1 | O75460 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 3/20 | 0.42 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28158091 | 0.86 | ERN1 (0.56) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| SCHEMBL3718244 | 0.82 | GPR3 (0.41) | ALDH1A1TRIM24TYRTRIM33MAPT | |
| SCHEMBL3724491 | 0.81 | ALDH1A3 (0.47) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| SCHEMBL4056812 | 0.80 | ALDH1A1 (0.59) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| SCHEMBL8550194 | 0.79 | AR (0.44) | ALDH1A1ERN1MAPTLMNAGAA | |
| SCHEMBL29169574 | 0.79 | MAPT (0.38) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| SCHEMBL1436514 | 0.79 | CYP1A1 (0.46) | ERN1MAPTCYP1A1CYP1B1LMNA | |
| SCHEMBL6142741 | 0.78 | SCN9A (0.44) | ALDH1A1MAPTCYP1A2CYP2C19EPHX2 | |
| SCHEMBL18957656 | 0.78 | LMNA (0.46) | ALDH1A1ERN1MAPTCYP1A2CYP2C19 | |
| SCHEMBL2633927 | 0.78 | GRIN2D (0.40) | ALDH1A1MAPTCYP1A2CYP2C19KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9612542-B2 | Electrostatic charge image developing toner, electrostatic charge image developer, and toner cartridge | FUJI XEROX CO., LTD. (JP) | 2017-04-04 | — | — | US | claimed |
| US-12552760-B2 | Compounds for increasing the nicotinamide adenine dinucleotide in a subject and methods of use thereof | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2026-02-17 | — | — | US | disclosed |
| US-20250138420-A1 | ENHANCED EUV PHOTORESISTS AND METHODS OF THEIR USE | IRRESISTIBLE MATERIALS LTD (GB) | 2025-05-01 | — | — | US | disclosed |
| CN-119487452-A | Enhanced EUV photoresist and method of use thereof | 亚历克斯·P·G·罗宾逊 | 2025-02-18 | — | — | CN | disclosed |
| CN-117229244-A | Orange ketone analogue and application thereof | 中国科学院新疆理化技术研究所 | 2023-12-15 | — | — | CN | disclosed |
| WO-2023227950-A1 | ENHANCED EUV PHOTORESISTS AND METHODS OF THEIR USE | ROBINSON ALEX P G (GB) | 2023-11-30 | — | — | WO | disclosed |
| US-20230365521-A1 | COMPOUNDS FOR INCREASING THE NICOTINAMIDE ADENINE DINUCLEOTIDE IN A SUBJECT AND METHODS OF USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-11-16 | — | — | US | disclosed |
| CN-108602811-B | FXR receptor agonists | 轩竹生物科技有限公司 | 2021-11-16 | — | — | CN | disclosed |
| CN-111777530-B | Method for catalyzing asymmetric Henry reaction of trifluoromethyl ketone | 中国科学院上海有机化学研究所 | 2021-09-03 | — | — | CN | disclosed |
| CN-111777530-A | Method for catalyzing asymmetric Henry reaction of trifluoromethyl ketone | 中国科学院上海有机化学研究所 | 2020-10-16 | — | — | CN | disclosed |
| US-20100120864-A1 | 2-AMINOOXAZOLINES AS TAAR1 LIGANDS | GALLEY GUIDO | 2010-05-13 | — | — | US | disclosed |
| WO-2010034982-A1 | LIGANDS FOR AGGREGATED TAU MOLECULES | WISTA LABORATORIES LTD. (SG) | 2010-04-01 | — | — | WO | disclosed |
| WO-2010034982-A1 | LIGANDS FOR AGGREGATED TAU MOLECULES | WISTA LABORATORIES LTD. (SG) | 2010-04-01 | — | — | WO | disclosed |
| EP-2114906-A1 | NOVEL 2-AMINOOXAZOLINES AS TAAR1 LIGANDS FOR CNS DISORDERS | F. Hoffmann-Roche AG (CH) | 2009-11-11 | — | — | EP | disclosed |
| WO-2009049165-A1 | NOVEL SEH INHIBITORS AND THEIR USE | SMITHKLINE BEECHAM CORPORATION (US) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009049157-A1 | NOVEL SEH INHIBITORS AND THEIR USE | SMITHKLINE BEECHAM CORPORATION (US) | 2009-04-16 | — | — | WO | disclosed |
| US-20080261920-A1 | 2-Aminooxazolines as TAAR1 ligands | F. HOFFMANN-LA ROCHE AG (CH) | 2008-10-23 | — | — | US | disclosed |
| WO-2008092785-A1 | NOVEL 2-AMINOOXAZOLINES AS TAAR1 LIGANDS FOR CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2008-08-07 | — | — | WO | disclosed |
| US-4730068-A | SPECIAL EFFECT ON BREAST CANCER | ASTA-WERKE AKTIENGESELLSCHAFT (DE) | 1988-03-08 | — | — | US | disclosed |
| EP-0193055-A1 | Antitumorals(1,2-diphenyl-ethylene diamine)-platinum (II) complexes | ASTA Pharma AG (DE) | 1986-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120864-A1 | 2-AMINOOXAZOLINES AS TAAR1 LIGANDS | TAAR1, TAAR5, NPY2R | ALDH1A1 708/4885TRIM24 3300/4885TYR 294/4885 |
| US-20230365521-A1 | COMPOUNDS FOR INCREASING THE NICOTINAMIDE ADENINE DINUCLEOTIDE IN A SUBJECT AND METHODS OF USE THEREOF | NNT, NNMT, SIRT1 | ALDH1A1 570/4885TRIM24 3378/4885TYR 3858/4885 |
| US-12552760-B2 | Compounds for increasing the nicotinamide adenine dinucleotide in a subject and methods of use thereof | NNMT, NNT, SARM1 | ALDH1A1 681/4885TRIM24 4114/4885TYR 4415/4885 |
| US-20080261920-A1 | 2-Aminooxazolines as TAAR1 ligands | TAAR1, TAAR5, NPY2R | ALDH1A1 708/4885TRIM24 3300/4885TYR 294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.